Annual Operating Expenses
$108.47 M
-$6.93 M-6.01%
31 December 2022
Summary:
Evelo Biosciences annual total operating expenses is currently $108.47 million, with the most recent change of -$6.93 million (-6.01%) on 31 December 2022. During the last 3 years, it has risen by +$16.58 million (+18.04%). EVLO annual operating expenses is now -6.01% below its all-time high of $115.40 million, reached on 31 December 2021.EVLO Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$10.39 M
-$7.57 M-42.14%
30 September 2023
Summary:
Evelo Biosciences quarterly total operating expenses is currently $10.39 million, with the most recent change of -$7.57 million (-42.14%) on 30 September 2023. EVLO quarterly operating expenses is now -68.24% below its all-time high of $32.71 million, reached on 30 September 2021.EVLO Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EVLO Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | +18.0% | -68.2% |
| 5 y5 years | +86.7% | -51.7% |
EVLO Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -6.0% | +18.0% | -68.2% | at low |
| 5 y | 5 years | -6.0% | +86.7% | -68.2% | at low |
| alltime | all time | -6.0% | +732.8% | -68.2% | +99.5% |
Evelo Biosciences Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $10.39 M(-42.1%) |
| June 2023 | - | $17.96 M(-27.9%) |
| Mar 2023 | - | $24.90 M(+18.1%) |
| Dec 2022 | $108.47 M(-6.0%) | $21.09 M(-27.4%) |
| Sept 2022 | - | $29.05 M(-1.8%) |
| June 2022 | - | $29.59 M(+3.0%) |
| Mar 2022 | - | $28.74 M(+4.3%) |
| Dec 2021 | $115.40 M(+25.6%) | $27.56 M(-15.7%) |
| Sept 2021 | - | $32.71 M(+18.3%) |
| June 2021 | - | $27.66 M(+0.7%) |
| Mar 2021 | - | $27.47 M(-2.6%) |
| Dec 2020 | $91.89 M | $28.20 M(+39.7%) |
| Sept 2020 | - | $20.18 M(-0.3%) |
| June 2020 | - | $20.25 M(-13.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $23.26 M(+2.6%) |
| Dec 2019 | $86.36 M(+48.6%) | $22.67 M(+5.5%) |
| Sept 2019 | - | $21.50 M(+0.5%) |
| June 2019 | - | $21.39 M(+2.8%) |
| Mar 2019 | - | $20.80 M(+30.1%) |
| Dec 2018 | $58.10 M(+111.0%) | $15.99 M(-2.8%) |
| Sept 2018 | - | $16.46 M(+8.1%) |
| June 2018 | - | $15.23 M(+46.1%) |
| Mar 2018 | - | $10.43 M(+29.2%) |
| Dec 2017 | $27.53 M(+111.4%) | $8.07 M(+0.4%) |
| Sept 2017 | - | $8.04 M(+29.3%) |
| June 2017 | - | $6.22 M(+19.4%) |
| Mar 2017 | - | $5.21 M |
| Dec 2016 | $13.03 M | - |
FAQ
- What is Evelo Biosciences annual total operating expenses?
- What is the all time high annual operating expenses for Evelo Biosciences?
- What is Evelo Biosciences quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Evelo Biosciences?
What is Evelo Biosciences annual total operating expenses?
The current annual operating expenses of EVLO is $108.47 M
What is the all time high annual operating expenses for Evelo Biosciences?
Evelo Biosciences all-time high annual total operating expenses is $115.40 M
What is Evelo Biosciences quarterly total operating expenses?
The current quarterly operating expenses of EVLO is $10.39 M
What is the all time high quarterly operating expenses for Evelo Biosciences?
Evelo Biosciences all-time high quarterly total operating expenses is $32.71 M